Jesper Folsted Kallehauge

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial

Lise Saksø Mortensen, Jørgen Johansen, Jesper Folsted Kallehauge et al. · Radiotherapy and Oncology · 2012 · 313 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Inclusion of functional information from perfusion SPECT improves predictive value of dose–volume parameters in lung toxicity outcome after radiotherapy for non-small cell lung cancer: A prospective study

Katherina P. Farr, Jesper Folsted Kallehauge, Ditte Sloth Møller et al. · Radiotherapy and Oncology · 2015 · 71 citations

Medicine, Nuclear Medicine, Radiation Oncology +17

Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours

Lene Haldbo‐Classen, Ali Amidi, Slávka Lukacova et al. · Radiotherapy and Oncology · 2020 · 71 citations

Medicine, Neuroscience, Oncology +16

PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice

Morten Busk, Lise Saksø Mortensen, Marianne Nordsmark et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 53 citations · Full text

Medicine, Nuclear Medicine, Oncology +12

Parametrial boosting in locally advanced cervical cancer: Combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy

Sandy Mohamed, Jesper Folsted Kallehauge, Lars Fokdal et al. · Brachytherapy · 2014 · 49 citations

Medicine, Oncology, Radiation Oncology +15